For the Culture By The Culture. ISSN: 3064-9331.
For decades, federal policy claimed cannabis had no accepted medical use while opioid prescriptions moved through the health care system by the tens of millions. Cannabis Lies Vol. 10 exposes the contradiction behind Schedule I, blocked research, medical cannabis patients, and the institutions that spent years pretending politics was medicine.
Saint Lucia has selected GrowerIQ as its national seed-to-sale traceability backbone, effectively finalizing a digital surveillance grid for its cannabis industry. By mandating enterprise software before establishing licensing frameworks, the government risks automating the exclusion of legacy farmers. This move trades cultural sovereignty for state-managed control, turning the cannabis industry into an extension of the database.
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
Mississippi maintains strict limits on medical cannabis after Governor Tate Reeves vetoed expansion bills on March 26, 2026. Patients remain unable to use cannabis in hospitals while eligibility and access rules stay tightly controlled. This feature examines what the veto blocks, how it affects patients, and what it means for the state’s growing cannabis market.
Thailand blew open its cannabis market, then tried to force it back under control. This feature tracks the country’s shift from prohibition to medical legalization, decriminalization, and regulatory backlash, exposing how weak enforcement, political pressure, and rushed policy turned a reform headline into a live case study in state correction.
This week’s Reefer Report Card tracks a familiar pattern in cannabis policy: delay dressed as progress. Federal lawmakers punted again on hemp regulation, states flirted with dismantling legal markets, and patients were left waiting. Oversight weakened, accountability faded, and reform stalled. Another week in weed, graded.
